Being a Good "Strategy Doctor": Why the Best Strategists Think Like Physicians

There is a moment that every seasoned strategist will recognise. You walk into a boardroom, briefed on the symptoms — falling margins, stalled growth, a grid connection project running months behind schedule — and before you have taken your seat, someone at the table has already handed you a diagnosis. "We just need to cut costs." "The market has changed." "It's a leadership problem." The prescription is ready. The patient hasn't even been examined.

This, more than almost anything else, is how strategic advice goes wrong.

The most effective strategists I have encountered operate less like management consultants armed with pre-packaged frameworks and more like exceptional physicians. They listen before they conclude. They probe before they prescribe. And they never mistake the presenting symptom for the underlying condition.

First, Do No Harm: Arriving Without an Agenda

The foundational principle of medicine — primum non nocere, first do no harm — translates directly into strategic practice. A strategist who enters an engagement with a pre-formed opinion is already dangerous. Confirmation bias, one of the most well-documented cognitive distortions in decision-making research, causes people to seek evidence that supports what they already believe and discount what contradicts it (Kahneman, Thinking, Fast and Slow, 2011). In a strategic context, this can lead organisations down expensive, time-consuming paths that treat the wrong problem entirely.

Roger Martin, in The Opposable Mind (2007), argued that the best strategic thinkers hold two conflicting ideas in their heads simultaneously, resisting the urge to resolve the tension prematurely. That intellectual patience — the willingness to sit with ambiguity before drawing conclusions — is precisely the quality that distinguishes a great diagnostician from a fast-talking advisor with a slide deck.

The Psychoanalyst's Discipline: Peeling Back the Layers

If the first physician analogy is about restraint, the second is about depth. Sigmund Freud's lasting contribution to professional practice was not his specific theories but his method: the belief that what a patient presents is rarely the whole story, and that the real material lies beneath — buried under habit, fear, institutional inertia, promotional desire, and carefully managed appearances.

In organisational life, the same dynamic applies. A company might present a strategic problem as a market-positioning challenge when the real issue is a dysfunctional executive team. An energy developer might describe a project delay as a supply chain problem when the root cause is an inadequate grid connection strategy developed two years too early — or too late. Edgar Schein's foundational work on organisational culture (Organizational Culture and Leadership, 1985) showed that the visible artefacts of a company — its processes, its org charts, its stated strategies — sit atop layers of assumptions and beliefs that rarely appear in any board paper.

The strategy doctor's job is to keep asking why — not aggressively, but persistently and with genuine curiosity. In the energy sector particularly, where technical complexity, regulatory pressure, and commercial risk sit in constant tension, surface-level diagnoses almost always miss the point.

Writing a Patient-Friendly Diagnosis

A brilliant diagnosis that no one understands is not a diagnosis — it is an academic exercise. This is where many strategists, particularly those from technical or financial backgrounds, stumble. The ability to translate complex insight into clear, actionable language is not a soft skill. It is a core professional competency.

Chip and Dan Heath, in Made to Stick (2007), identified simplicity, unexpectedness, and concreteness as the defining qualities of ideas that land and endure. The best strategic documents share these qualities. They do not hide behind jargon. They do not bury the recommendation on page forty-seven. They lead with the insight, explain the evidence, and tell the reader clearly what needs to happen — and why it matters.

In healthcare, this is called health literacy — the ability to communicate clinical findings in a way the patient can act on. In strategy, it is simply good writing backed by clear thinking. A strategic report that a Chief Executive cannot explain to their board within five minutes has already failed, regardless of the quality of the analysis beneath it.

The Prescription Is Not the End: Monitoring and Adaptation

Perhaps the most undervalued dimension of great strategic advice is what happens after the report is delivered. Too many consultants produce their analysis, present their recommendations, invoice their fee, and disappear — leaving the client to implement in isolation. This is the strategic equivalent of a doctor writing a prescription and never seeing the patient again.

Good medicine is iterative. Dosages are adjusted. Side effects are monitored. New symptoms emerge and require attention. The same is true of strategy. John Kotter's research on change management (Leading Change, 1996) consistently found that strategic initiatives fail not because the diagnosis was wrong, but because implementation was treated as a separate, largely administrative activity rather than an ongoing clinical process requiring continued expert attention.

The best strategy doctors build monitoring into their methodology from the outset. They define what "improvement" looks like before the programme begins, establish regular review points, and remain genuinely curious about whether the prescription is working — or whether it needs to change. In the UK energy sector, where regulatory landscapes shift, grid connection queues evolve, and technology economics move faster than almost any other industry, this adaptive capacity is not optional. It is essential.

Bedside Manner: The Strategic Value of Being Heard

There is a final quality that separates the truly exceptional strategist from the merely technically competent one, and it is perhaps the most human of all: the ability to make clients feel genuinely heard.

Research in medical practice consistently shows that patients who feel listened to are more likely to follow treatment plans, report concerns early, and achieve better outcomes (Lewin et al., BMJ, 2001). The mechanism is straightforward — when people feel understood, they trust. And when they trust, they are honest. That honesty, in turn, gives the clinician the information they need to do their job properly.

In strategy, the same feedback loop operates. Executives who feel that their strategist truly understands their context — the pressures they face, the history they carry, the constraints that don't appear in any data set — will share the information that actually matters. They will flag the awkward truth that didn't make it into the board presentation. They will admit the assumption that everyone knows is flawed but nobody has said aloud.

This is not about charm or flattery. It is about creating the conditions in which honest, useful conversations can take place. It is about being genuinely curious rather than performatively sympathetic. And it is about recognising that the client, like the patient, is the expert on their own experience — even if they need help understanding what that experience means.

The Diagnosis We Often Avoid

The irony is that the strategy profession itself could benefit from this kind of honest diagnosis. Too much of what passes for strategic advice is, in reality, the application of generic frameworks to bespoke problems, the recycling of last year's thinking with this year's branding. The sector rewards speed and confidence over depth and humility.

The organisations that engage genuinely skilled strategy doctors — those who listen before they speak, probe before they prescribe, communicate with clarity, adapt with intelligence, and maintain the kind of trusted relationships that allow real conversations to happen — consistently outperform those that do not. The evidence for this, across decades of management research and real-world case study, is unambiguous (McKinsey Global Institute, Strategy in the Age of Digital Turbulence, 2018; Rumelt, Good Strategy/Bad Strategy, 2011).

The best strategists are not the most brilliant analysts in the room. They are the most disciplined listeners, the most honest writers, and the most reliable partners in the long work of organisational health.

That, in the end, is what it means to be a great strategy doctor.

At CM Energy Insight, we bring this diagnostic discipline to the UK energy sector — helping developers, Government agencies, investors, and operators cut through complexity to find the strategies that genuinely work. If you'd like to explore what a rigorous strategic review might reveal for your organisation, get in touch.